Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotiris Missailidis

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Bioconjugate Chemistry|December 17, 2009
Modification of thiol functionalized aptamers by conjugation of synthetic polymersChiara Da Pieve, Paul Williams, David M Haddleton, et al.
Journal of Drug Targeting|January 29, 2013
Aptamer-based nanoparticles for cancer targetingLucas Torres Miranda Sá, Suzanne Simmons, Sotiris Missailidis, et al.
Artificial Cells, Nanomedicine, and Biotechnology|February 18, 2017
Comparison of biodistribution profile of monoclonal antibodies nanoparticles and aptamers in rats with breast cancerCristal Cerqueira-Coutinho, Sotiris Missailidis, Jéssica Alessandra-Perini, et al.
International Journal of Pharmaceutics|April 5, 2017
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancerCarlos E B de Almeida, Lais Nascimento Alves, Henrique F Rocha, et al.
Pharmaceutics|August 28, 2021
Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer TherapyHuma Khan, Vaidehi Makwana, Sofia Nascimento Dos Santos, et al.
Oncology Research|January 29, 2003
Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug designSotiris Missailidis, Johnson Stanslas, Chetna Modi, et al.
Oncology|April 18, 2012
Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targetingLucas Torres Miranda Sá, Claudia Pessoa, Assuero Silva Meira, et al.
Pharmaceutics|January 1, 2020
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of CancerAna Paula Dinis Ano Bom, Patrícia Cristina da Costa Neves, Carlos Eduardo Bonacossa de Almeida, et al.
Experimental Cell Research|August 8, 2018
Effects of ionizing radiation and HPSE1 inhibition on the invasion of oral tongue carcinoma cells on human extracellular matrices in vitroOtto Väyrynen, Markku Piippo, Hannaleena Jämsä, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffoldStefano Alcaro, Anna Artese, James N Iley, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Bioconjugate Chemistry|December 17, 2009
Modification of thiol functionalized aptamers by conjugation of synthetic polymersChiara Da Pieve, Paul Williams, David M Haddleton, et al.
Journal of Drug Targeting|January 29, 2013
Aptamer-based nanoparticles for cancer targetingLucas Torres Miranda Sá, Suzanne Simmons, Sotiris Missailidis, et al.
Artificial Cells, Nanomedicine, and Biotechnology|February 18, 2017
Comparison of biodistribution profile of monoclonal antibodies nanoparticles and aptamers in rats with breast cancerCristal Cerqueira-Coutinho, Sotiris Missailidis, Jéssica Alessandra-Perini, et al.
International Journal of Pharmaceutics|April 5, 2017
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancerCarlos E B de Almeida, Lais Nascimento Alves, Henrique F Rocha, et al.
Pharmaceutics|August 28, 2021
Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer TherapyHuma Khan, Vaidehi Makwana, Sofia Nascimento Dos Santos, et al.
Oncology Research|January 29, 2003
Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug designSotiris Missailidis, Johnson Stanslas, Chetna Modi, et al.
Oncology|April 18, 2012
Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targetingLucas Torres Miranda Sá, Claudia Pessoa, Assuero Silva Meira, et al.
Pharmaceutics|January 1, 2020
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of CancerAna Paula Dinis Ano Bom, Patrícia Cristina da Costa Neves, Carlos Eduardo Bonacossa de Almeida, et al.
Experimental Cell Research|August 8, 2018
Effects of ionizing radiation and HPSE1 inhibition on the invasion of oral tongue carcinoma cells on human extracellular matrices in vitroOtto Väyrynen, Markku Piippo, Hannaleena Jämsä, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffoldStefano Alcaro, Anna Artese, James N Iley, et al.
Pageof 5